logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Aromatic Amino Acid Decarboxylation Inhibitor class drugs

    FiltersReset Filters
    7 results

    • carbidopa

      (Carbidopa)
      Edenbridge Pharmaceuticals LLC.
      Usage: Carbidopa tablets are indicated for use with carbidopa-levodopa or levodopa to treat symptoms of idiopathic Parkinson's disease, postencephalitic parkinsonism, and symptomatic parkinsonism due to nervous system injury. They help reduce nausea, allow for lower levodopa doses, and facilitate dosage titration.

    • carbidopa and levodopa

      (Carbidopa and levodopa)
      Advagen Pharma Ltd
      Usage: Carbidopa and levodopa extended-release tablets are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism resulting from carbon monoxide or manganese intoxication.

    • carbidopa-levodopa

      (carbidopa and levodopa)
      Advagen Pharma Ltd.,
      Usage: Carbidopa and levodopa tablets are indicated for treating Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism following carbon monoxide or manganese intoxication. Carbidopa enhances levodopa's effectiveness, allowing lower doses, reducing nausea, and facilitating faster titration.

    • dhivy

      (Carbidopa Levodopa)
      Avion Pharmaceuticals, LLC
      Usage: DHIVY is indicated for treating Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism resulting from carbon monoxide or manganese intoxication.

    • duopa

      (Carbidopa and Levodopa)
      AbbVie Inc.
      Usage: DUOPA® is indicated for treating motor fluctuations in patients with advanced Parkinson’s disease.

    • rytary

      (Carbidopa and Levodopa)
      Amneal Pharmaceuticals LLC
      Usage: RYTARY is indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism associated with carbon monoxide or manganese intoxication.

    • vyalev

      (foscarbidopa/foslevodopa)
      AbbVie Inc.
      Usage: VYALEV is indicated for treating motor fluctuations in adults with advanced Parkinson's disease.